Ultrasound nearly blind to normalcy in parathyroid glands

Ultrasound is not up to the job of identifying normal parathyroid glands, according to a study conducted at Inje University in South Korea and published July 15 in La Radiologia Medica, the official journal of the Italian Society of Medical Radiology.

The authors focused on 36 patients who were imaged by a radiologist using ultrasound prior to undergoing hemithyroidectomy (removal of half the thyroid gland) and had sufficient surgical data for analyzing after the operation.

They found ultrasound identified normal parathyroid glands, which regulate calcium distribution in the blood and bones, in only three patients for whom the finding was corroborated by surgical findings.

In two patients, the ultrasound results different from the surgical findings.

In some 31 of the 36 patients, ultrasound did not detect a normal parathyroid gland.

With an accuracy rate of just 8.3 percent, the authors conclude, ultrasound “cannot be used for identification of normal parathyroid glands.”

The authors state that theirs is the first prospective study to investigate the detection of normal parathyroid glands and their features using real-time ultrasound.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease. 

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.